Form 8-K - Current report:
SEC Accession No. 0000950170-24-022053
Filing Date
2024-02-28
Accepted
2024-02-28 16:05:13
Documents
14
Period of Report
2024-02-28
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K rxst-20240228.htm   iXBRL 8-K 40340
2 EX-99.1 rxst-ex99_1.htm EX-99.1 305484
3 GRAPHIC img261313502_0.jpg GRAPHIC 2587
  Complete submission text file 0000950170-24-022053.txt   475184

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rxst-20240228.xsd EX-101.SCH 23862
15 EXTRACTED XBRL INSTANCE DOCUMENT rxst-20240228_htm.xml XML 4511
Mailing Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656
Business Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656 949-521-7822
RxSight, Inc. (Filer) CIK: 0001111485 (see all company filings)

EIN.: 943268801 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40690 | Film No.: 24695193
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)